Stralem & Co. Inc. Sells 32,695 Shares of UnitedHealth Group Inc (UNH)

Stralem & Co. Inc. lessened its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 25.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 93,900 shares of the healthcare conglomerate’s stock after selling 32,695 shares during the quarter. UnitedHealth Group comprises 3.5% of Stralem & Co. Inc.’s portfolio, making the stock its 4th biggest holding. Stralem & Co. Inc.’s holdings in UnitedHealth Group were worth $20,701,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Capital International Investors grew its holdings in UnitedHealth Group by 399.3% during the 3rd quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after buying an additional 3,304,902 shares in the last quarter. Jennison Associates LLC grew its holdings in UnitedHealth Group by 146.0% during the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after buying an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC grew its holdings in UnitedHealth Group by 1,820.1% during the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after buying an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. grew its holdings in UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after buying an additional 1,588,516 shares in the last quarter. Finally, Parametric Portfolio Associates LLC grew its holdings in UnitedHealth Group by 77.3% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after buying an additional 1,562,661 shares in the last quarter. Institutional investors and hedge funds own 85.65% of the company’s stock.

A number of equities analysts have recently commented on the company. Deutsche Bank lifted their target price on UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 target price (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Friday, December 1st. Jefferies Group reiterated a “buy” rating and issued a $248.00 target price on shares of UnitedHealth Group in a report on Friday, December 1st. Finally, Evercore ISI reiterated an “outperform” rating and issued a $255.00 target price (up previously from $235.00) on shares of UnitedHealth Group in a report on Friday, January 12th. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $243.22.

Shares of UnitedHealth Group Inc (NYSE UNH) opened at $226.66 on Wednesday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58. The firm has a market capitalization of $219,650.00, a price-to-earnings ratio of 23.86, a price-to-earnings-growth ratio of 1.34 and a beta of 0.70. UnitedHealth Group Inc has a 1 year low of $157.52 and a 1 year high of $250.79.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. UnitedHealth Group’s revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the company posted $2.11 EPS. equities research analysts predict that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date of this dividend is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.58%.

In other news, Director Michele J. Hooper sold 5,000 shares of the business’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the completion of the transaction, the director now directly owns 36,989 shares of the company’s stock, valued at approximately $8,218,955.80. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 53,396 shares of company stock valued at $12,262,067. 0.89% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: This story was originally published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://ledgergazette.com/2018/02/21/stralem-co-inc-sells-32695-shares-of-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply